[Progress in cancer treatment with histone deacetylase inhibitor]

Zhonghua Zhong Liu Za Zhi. 2013 Jul;35(7):481-5.
[Article in Chinese]
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Aminopyridines / therapeutic use
  • Antineoplastic Agents / therapeutic use*
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Benzamides / therapeutic use
  • Clinical Trials as Topic
  • Depsipeptides / therapeutic use
  • Histone Deacetylase Inhibitors / therapeutic use*
  • Histone Deacetylases / metabolism
  • Humans
  • Hydroxamic Acids / therapeutic use
  • Indoles / therapeutic use
  • Neoplasms / drug therapy*
  • Neoplasms / enzymology
  • Panobinostat
  • Sulfonamides / therapeutic use
  • Vorinostat

Substances

  • Aminopyridines
  • Antineoplastic Agents
  • Benzamides
  • Depsipeptides
  • Histone Deacetylase Inhibitors
  • Hydroxamic Acids
  • Indoles
  • Sulfonamides
  • Vorinostat
  • N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide
  • Panobinostat
  • romidepsin
  • Histone Deacetylases
  • belinostat